Form 4: Relmada Therapeutics Director Casamento Acquires 13,000 Shares

Director Charles J. Casamento of Relmada Therapeutics, Inc. purchased 13,000 shares of common stock at $2.56 per share on September 9, 2024.

Summary

• On September 9, 2024, Charles J. Casamento, a director of Relmada Therapeutics, Inc., acquired 13,000 shares of the company's common stock.
• The purchase price was $2.56 per share.
• Following the transaction, Mr. Casamento directly owns 13,000 shares of Relmada Therapeutics.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but the transaction is relatively small and doesn't provide a strong signal.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into a company's prospects. A director's purchase is generally viewed more favorably than a sale.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Relmada Therapeutics, RLMD, Charles J. Casamento, Director, Stock Purchase, Form 4, Beneficial Ownership, Insider Trading